Sacituzumab Tirumotecan in Previously Treated TROP2-Positive Advanced Biliary Tract Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sacituzumab Tirumotecan in Previously Treated TROP2-Positive Advanced Biliary Tract Cancer	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm	Not yet recruiting	Phase 2	2026-07-14		NCT07701122

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	52
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	319

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials